UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 13, 2006
Lifeline Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Colorado
|
|
000-30489
|
|
90-0224471 |
|
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.) |
| |
|
|
| 6400 South Fiddler’s Green Circle, Suite 1970, Greenwood Village, CO
|
|
80111 |
|
|
|
|
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code: (720) 488-1711
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
TABLE OF CONTENTS
Item 2.02 Results of Operations and Financial Condition
On November 13, 2006, Lifeline Therapeutics, Inc. issued a press release entitled, “Lifeline
Therapeutics, Inc. Announces 1Q FY2007 Financial and Operating Results”. The press release is
attached as Exhibit 99.1 hereto.
Item 7.01 Regulation FD Disclosure
On November 13, 2006, Lifeline Therapeutics, Inc. issued a press release entitled “Lifeline
Therapeutics, Inc. Announces 1Q FY2007 Financial and Operating Results.” The press release is
attached as Exhibit 99.1 hereto.
Item 9.01 Exhibits
99.1 Press release, dated November 13, 2006, entitled “Lifeline Therapeutics, Inc. Announces
1Q FY2007 Financial and Operating Results.”
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly
authorized.
Date: November 13, 2006
| |
|
|
|
|
|
|
| |
|
LIFELINE THERAPEUTICS, INC. |
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Stephen K. Onody |
|
|
|
|
|
|
Stephen K. Onody
|
|
|
|
|
|
|
Chief Executive Officer |
|
|